FI910455A - Komposition med foerbaettrad penetration. - Google Patents

Komposition med foerbaettrad penetration. Download PDF

Info

Publication number
FI910455A
FI910455A FI910455A FI910455A FI910455A FI 910455 A FI910455 A FI 910455A FI 910455 A FI910455 A FI 910455A FI 910455 A FI910455 A FI 910455A FI 910455 A FI910455 A FI 910455A
Authority
FI
Finland
Prior art keywords
layer
foerbaettrad
penetration
composition
active medicament
Prior art date
Application number
FI910455A
Other languages
English (en)
Other versions
FI910455A0 (fi
Inventor
Majid Mahjour
Bernadette Mauser
Edwards Eonchao Linn
Zahra Rashidbaigi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512850&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI910455(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to IE39089A priority Critical patent/IE62871B1/en
Priority to ZA891031A priority patent/ZA891031B/xx
Priority to NZ228094A priority patent/NZ228094A/xx
Priority to AU30258/89A priority patent/AU611771B2/en
Priority to PH38267A priority patent/PH26548A/en
Priority to AT89104017T priority patent/ATE90571T1/de
Priority to EP89104017A priority patent/EP0332147B1/en
Priority to JP5306989A priority patent/JP2939264B2/ja
Priority to DK198901096A priority patent/DK175621B1/da
Priority to ES89104017T priority patent/ES2056981T3/es
Priority to DE89104017T priority patent/DE68907081T2/de
Priority to US07/391,808 priority patent/US5019395A/en
Priority claimed from ZA91624A external-priority patent/ZA91624B/xx
Priority to ZA91624A priority patent/ZA91624B/xx
Priority to NZ236921A priority patent/NZ236921A/en
Priority to CA002035143A priority patent/CA2035143A1/en
Priority to IE30591A priority patent/IE64308B1/en
Priority to AU70061/91A priority patent/AU634015B2/en
Publication of FI910455A0 publication Critical patent/FI910455A0/fi
Priority to FI910455A priority patent/FI910455A/fi
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to KR1019910001750A priority patent/KR100191456B1/ko
Priority to NO91910403A priority patent/NO910403L/no
Priority to JP3038921A priority patent/JPH04338325A/ja
Priority to PT96779A priority patent/PT96779B/pt
Priority to EP91102354A priority patent/EP0499662B1/en
Priority to DK91102354.7T priority patent/DK0499662T3/da
Priority to DE69105480T priority patent/DE69105480T2/de
Priority to ES91102354T priority patent/ES2064780T3/es
Priority to AT91102354T priority patent/ATE114481T1/de
Publication of FI910455A publication Critical patent/FI910455A/fi
Priority to GR950400229T priority patent/GR3014988T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physical Water Treatments (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Laminated Bodies (AREA)
FI910455A 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration. FI910455A (fi)

Priority Applications (28)

Application Number Priority Date Filing Date Title
IE39089A IE62871B1 (en) 1988-03-08 1989-02-07 Compositions with enhanced penetration
ZA891031A ZA891031B (en) 1988-03-08 1989-02-09 Compositions with enhanced penetration
NZ228094A NZ228094A (en) 1988-03-08 1989-02-22 Transmembranally administerable compositions containing bioaffecting agent and gelling agent
AU30258/89A AU611771B2 (en) 1988-03-08 1989-02-23 Compositions with enhanced penetration
PH38267A PH26548A (en) 1988-03-08 1989-03-01 Compositions with enhanced penetration
DE89104017T DE68907081T2 (de) 1988-03-08 1989-03-07 Mittel mit erhöhtem Penetrationsvermögen.
EP89104017A EP0332147B1 (en) 1988-03-08 1989-03-07 Compositions with enhanced penetration
AT89104017T ATE90571T1 (de) 1988-03-08 1989-03-07 Mittel mit erhoehtem penetrationsvermoegen.
JP5306989A JP2939264B2 (ja) 1988-03-08 1989-03-07 浸透強化組成物
DK198901096A DK175621B1 (da) 1988-03-08 1989-03-07 Præparater med forbedret penetration
ES89104017T ES2056981T3 (es) 1988-03-08 1989-03-07 Composiciones dotadas de una capacidad de penetracion mejorada.
US07/391,808 US5019395A (en) 1988-03-08 1989-08-09 Compositions with enhanced penetration
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
AT91102354T ATE114481T1 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem penetrationsvermögen.
ES91102354T ES2064780T3 (es) 1988-03-08 1991-02-19 Composiciones con penetracion mejorada.
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration
DK91102354.7T DK0499662T3 (da) 1988-03-08 1991-02-19 Præparater med forøget penetration
DE69105480T DE69105480T2 (de) 1988-03-08 1991-02-19 Mittel mit erhöhtem Penetrationsvermögen.
GR950400229T GR3014988T3 (en) 1988-03-08 1995-02-08 Compositions with enhanced penetration.

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16532288A 1988-03-08 1988-03-08
NZ236921A NZ236921A (en) 1988-03-08 1991-01-28 Laminate for transmembranal administration of a drug
ZA91624A ZA91624B (en) 1991-01-28 1991-01-28 Delivery device for compositions with enhanced penetration and process for preparing same
CA002035143A CA2035143A1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
IE30591A IE64308B1 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
AU70061/91A AU634015B2 (en) 1988-03-08 1991-01-29 Compositions with enhanced penetration
FI910455A FI910455A (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.
KR1019910001750A KR100191456B1 (ko) 1988-03-08 1991-02-01 침투력이 향상된 조성물
NO91910403A NO910403L (no) 1988-03-08 1991-02-01 Fremgangsmaate for fremstilling av farmasoeytisk preparat.
JP3038921A JPH04338325A (ja) 1988-03-08 1991-02-12 増強された浸透性を有する組成物
PT96779A PT96779B (pt) 1988-03-08 1991-02-15 Laminado composito de duas camadas
EP91102354A EP0499662B1 (en) 1988-03-08 1991-02-19 Compositions with enhanced penetration

Publications (2)

Publication Number Publication Date
FI910455A0 FI910455A0 (fi) 1991-01-30
FI910455A true FI910455A (fi) 1992-07-31

Family

ID=32512850

Family Applications (1)

Application Number Title Priority Date Filing Date
FI910455A FI910455A (fi) 1988-03-08 1991-01-30 Komposition med foerbaettrad penetration.

Country Status (16)

Country Link
EP (2) EP0332147B1 (fi)
JP (2) JP2939264B2 (fi)
KR (1) KR100191456B1 (fi)
AT (2) ATE90571T1 (fi)
AU (2) AU611771B2 (fi)
CA (1) CA2035143A1 (fi)
DE (2) DE68907081T2 (fi)
DK (2) DK175621B1 (fi)
ES (2) ES2056981T3 (fi)
FI (1) FI910455A (fi)
GR (1) GR3014988T3 (fi)
IE (2) IE62871B1 (fi)
NO (1) NO910403L (fi)
NZ (2) NZ228094A (fi)
PH (1) PH26548A (fi)
PT (1) PT96779B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration
WO1991015176A1 (en) * 1990-04-06 1991-10-17 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
DE4334919A1 (de) * 1993-10-13 1995-04-20 Liedtke Pharmed Gmbh Grenzwertig wirksame Arzneiformen mit Betablockern
KR100192149B1 (ko) * 1994-10-24 1999-06-15 이시노 요시푸사 경피 투여형 제제
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US6916486B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US6998138B2 (en) 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6916487B2 (en) 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6646379B1 (en) 1998-12-25 2003-11-11 Matsushita Electric Industrial Co., Ltd. Metal vapor discharge lamp having cermet lead-in with improved luminous efficiency and flux rise time
WO2000035439A1 (en) * 1998-12-11 2000-06-22 Bakulesh Mafatlal Khamar The process for manufacturing formulation of topical beta blockers with improved efficacy
DE10004790B4 (de) * 2000-02-01 2004-09-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
CN101287470B (zh) 2005-10-12 2012-10-17 优尼麦德药物股份有限公司 改良的睾酮凝胶及使用方法
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH657047A5 (fr) * 1981-10-23 1986-08-15 Oreal Composition sous forme de shampooing a base d'un compose d'anthraline.
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
US4816456A (en) * 1986-10-01 1989-03-28 Summers William K Administration of monoamine acridines in cholinergic neuronal deficit states
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IE62871B1 (en) * 1988-03-08 1995-03-08 Warner Lambert Co Compositions with enhanced penetration

Also Published As

Publication number Publication date
JPH04338325A (ja) 1992-11-25
JP2939264B2 (ja) 1999-08-25
ATE114481T1 (de) 1994-12-15
ATE90571T1 (de) 1993-07-15
PH26548A (en) 1992-08-19
DE68907081T2 (de) 1993-10-21
FI910455A0 (fi) 1991-01-30
ES2056981T3 (es) 1994-10-16
DE69105480D1 (de) 1995-01-12
AU7006191A (en) 1992-08-20
EP0499662B1 (en) 1994-11-30
EP0332147B1 (en) 1993-06-16
IE910305A1 (en) 1992-07-29
IE62871B1 (en) 1995-03-08
DE69105480T2 (de) 1995-04-06
CA2035143A1 (en) 1992-07-30
NZ228094A (en) 1991-09-25
EP0332147A3 (en) 1990-09-19
ES2064780T3 (es) 1995-02-01
KR100191456B1 (ko) 1999-06-15
JPH01272519A (ja) 1989-10-31
EP0499662A1 (en) 1992-08-26
DK109689A (da) 1989-09-09
NZ236921A (en) 1993-08-26
NO910403L (no) 1992-08-03
AU634015B2 (en) 1993-02-11
DK0499662T3 (da) 1995-05-15
IE64308B1 (en) 1995-07-26
KR920016085A (ko) 1992-09-24
AU3025889A (en) 1989-09-14
NO910403D0 (no) 1991-02-01
DE68907081D1 (de) 1993-07-22
GR3014988T3 (en) 1995-05-31
PT96779A (pt) 1992-08-31
PT96779B (pt) 1998-09-30
AU611771B2 (en) 1991-06-20
DK109689D0 (da) 1989-03-07
DK175621B1 (da) 2004-12-27
IE890390L (en) 1989-09-08
EP0332147A2 (en) 1989-09-13

Similar Documents

Publication Publication Date Title
FI910455A0 (fi) Komposition med foerbaettrad penetration.
DK241090A (da) Lamineret komposit til transdermal administration af fentanyl
AU8249987A (en) Diffusion matrix for transdermal drug administration
KR900007595A (ko) 개선된 라미네이트 복합체 및 그 제조 방법
GB2234024B (en) Carbon composite laminated structures
DE3582169D1 (de) Polyepoxyd und halogeniertes dihydriertes phenol enthaltende vernetzbare zusammensetzungen und impraegnierte substrate und so hergestellte laminate.
AU565069B2 (en) Composite leg platform
DE3853868T2 (de) Wärmehärtende Harzzusammensetzung und Prepreg und laminierter Schichtstoff, die diese verwenden.
BR8904152A (pt) Composicao,composicao curavel,verniz de laminacao,substrato,laminado e composicao de agente de cura
DE3785107D1 (de) Prepreg und dessen komposit.
EP1106221A3 (de) Holzschiene für ein Fahrgeschäft sowie Verfahren zur Herstellung und zum Montieren einer solchen Holzschiene
DE68917417T2 (de) Feine Bereiche aufweisende Verbundfolien aus Polyimid-Mischungen.
DE3578835D1 (de) Haertbare gummizusammensetzung.
DK609787A (da) Let konstruktionselement
JPS6487618A (en) Hardening agent composition, laminating vanish and laminated board
DE68926073D1 (de) Harzzusammensetzung für Laminate
IT8722032A0 (it) Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione.
JPS6452942A (en) Vibration-damping composite board
DE3860778D1 (de) Flammhemmende harzzusammensetzung und damit hergestelltes laminat.
IT8821606A0 (it) Tavellone prefabbricato per la realizzazione di strutture composite, particolarmente solai e tavellonati in genere.
ES521091A0 (es) Mejoras en el objeto de la patente principal no 513.956 por procedimiento para la carbonilacion de olefinas y esteres organicos.

Legal Events

Date Code Title Description
FD Application lapsed